{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:46:13Z","timestamp":1791233173453,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.intimp.2024.111892","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T15:03:17Z","timestamp":1713970997000},"page":"111892","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The quantity, function and anti-tumor effect of Mucosal associated invariant T cells in patients with bladder cancer"],"prefix":"10.1016","volume":"133","author":[{"given":"Baodan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0337-8939","authenticated-orcid":false,"given":"Yongyong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10061","key":"10.1016\/j.intimp.2024.111892_b0005","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","article-title":"Bladder cancer","volume":"388","author":"Kamat","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.intimp.2024.111892_b0010","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.intimp.2024.111892_b0015","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.eururo.2016.06.020","article-title":"Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer","volume":"71","author":"Alfred","year":"2017","journal-title":"Eur. Urol."},{"issue":"7492","key":"10.1016\/j.intimp.2024.111892_b0020","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature12965","article-title":"Comprehensive molecular characterization of urothelial bladder carcinoma","volume":"507","author":"Cancer Genome Atlas Research Network","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.intimp.2024.111892_b0025","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavitary Bacillus calmette-guerin in the treatment of superficial bladder tumors","volume":"116","author":"Morales","year":"1976","journal-title":"J. Urol."},{"issue":"4","key":"10.1016\/j.intimp.2024.111892_b0030","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1158\/2326-6066.CIR-18-0671","article-title":"Intravesical Ty21a vaccine promotes dendritic cells and T cell-mediated tumor regression in the MB49 bladder cancer model","volume":"7","author":"Domingos-Pereira","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.intimp.2024.111892_b0035","doi-asserted-by":"crossref","unstructured":"Daniel Peter Petrylak TP, J.B.F.Y., A phase Ia study of MPDL3280A (anti-PDL1): Updated response and survival data in urothelial bladder cancer (UBC). J. Clin. Oncol., 2015. (suppl; abstr 4501)(33): p. 4501.","DOI":"10.1200\/jco.2015.33.15_suppl.4501"},{"issue":"81","key":"10.1016\/j.intimp.2024.111892_b0040","first-page":"120","article-title":"Advances in cancer immunotherapy","volume":"15","author":"Snook","year":"2013","journal-title":"Discov. Med."},{"issue":"5","key":"10.1016\/j.intimp.2024.111892_b0045","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1517\/14740338.2013.795944","article-title":"Cancer immunotherapies, their safety and toxicity","volume":"12","author":"Alatrash","year":"2013","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.intimp.2024.111892_b0050","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1038\/ncomms4866","article-title":"Parallel T-cell cloning and deep sequencing of human MAIT cells reveal stable oligoclonal TCRbeta repertoire","volume":"5","author":"Lepore","year":"2014","journal-title":"Nat. Commun."},{"issue":"6928","key":"10.1016\/j.intimp.2024.111892_b0055","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nature01433","article-title":"Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1","volume":"422","author":"Treiner","year":"2003","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.intimp.2024.111892_b0060","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.humimm.2015.09.002","article-title":"T-cell receptor repertoire of human peripheral CD161hiTRAV1-2+ MAIT cells revealed by next generation sequencing and single cell analysis","volume":"76","author":"Held","year":"2015","journal-title":"Hum. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2024.111892_b0065","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.coi.2006.07.001","article-title":"CD1d- and MR1-restricted invariant T cells: of mice and men","volume":"18","author":"Treiner","year":"2006","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.intimp.2024.111892_b0070","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.exger.2013.11.003","article-title":"Circulating mucosal-associated invariant T cell levels and their cytokine levels in healthy adults","volume":"49","author":"Lee","year":"2014","journal-title":"Exp. Gerontol."},{"issue":"4","key":"10.1016\/j.intimp.2024.111892_b0075","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1182\/blood-2010-08-303339","article-title":"Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells","volume":"117","author":"Dusseaux","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.intimp.2024.111892_b0080","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.4049\/jimmunol.176.3.1618","article-title":"MR1-restricted V alpha 19i mucosal-associated invariant T cells are innate T cells in the gut lamina propria that provide a rapid and diverse cytokine response","volume":"176","author":"Kawachi","year":"2006","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2024.111892_b0085","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1073\/pnas.0914839107","article-title":"Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties","volume":"107","author":"Billerbeck","year":"2010","journal-title":"PNAS"},{"issue":"6","key":"10.1016\/j.intimp.2024.111892_b0090","doi-asserted-by":"crossref","first-page":"e1004210","DOI":"10.1371\/journal.ppat.1004210","article-title":"Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver","volume":"10","author":"Jo","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.intimp.2024.111892_b0095","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1038\/ncomms4143","article-title":"Acquisition of innate-like microbial reactivity in mucosal tissues during human fetal MAIT-cell development","volume":"5","author":"Leeansyah","year":"2014","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.intimp.2024.111892_b0100","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1038\/jid.2014.261","article-title":"The IL-17A-producing CD8+ T-cell population in psoriatic lesional skin comprises mucosa-associated invariant T cells and conventional T cells","volume":"134","author":"Teunissen","year":"2014","journal-title":"J. Invest.Dermatol"},{"issue":"4","key":"10.1016\/j.intimp.2024.111892_b0105","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI78941","article-title":"Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients","volume":"125","author":"Magalhaes","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.intimp.2024.111892_b0110","doi-asserted-by":"crossref","first-page":"5775","DOI":"10.4049\/jimmunol.1402945","article-title":"Altered distribution and increased IL-17 production by mucosal-associated invariant T cells in adult and childhood obesity","volume":"194","author":"Carolan","year":"2015","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2024.111892_b0115","doi-asserted-by":"crossref","first-page":"e1000407","DOI":"10.1371\/journal.pbio.1000407","article-title":"Human mucosal associated invariant T cells detect bacterially infected cells","volume":"8","author":"Gold","year":"2010","journal-title":"PLoS Biol."},{"issue":"8","key":"10.1016\/j.intimp.2024.111892_b0120","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/ni.1890","article-title":"Antimicrobial activity of mucosal-associated invariant T cells","volume":"11","author":"Le Bourhis","year":"2010","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.111892_b0125","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/eji.201343509","article-title":"CD161++ CD8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner","volume":"44","author":"Ussher","year":"2014","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2024.111892_b0130","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/imm.12461","article-title":"High expression of CD26 accurately identifies human bacteria-reactive MR1-restricted MAIT cells","volume":"145","author":"Sharma","year":"2015","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.intimp.2024.111892_b0135","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/mi.2014.81","article-title":"MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets","volume":"8","author":"Kurioka","year":"2015","journal-title":"Mucosal Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2024.111892_b0140","doi-asserted-by":"crossref","first-page":"e1003681","DOI":"10.1371\/journal.ppat.1003681","article-title":"MAIT cells detect and efficiently lyse bacterially-infected epithelial cells","volume":"9","author":"Le Bourhis","year":"2013","journal-title":"PLoS Pathog."},{"issue":"12","key":"10.1016\/j.intimp.2024.111892_b0145","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s00262-015-1764-7","article-title":"Increased tumor infiltration by mucosal-associated invariant T cells correlates with poor survival in colorectal cancer patients","volume":"64","author":"Zabijak","year":"2015","journal-title":"CancerImmunol Immunother"},{"issue":"7","key":"10.1016\/j.intimp.2024.111892_b0150","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.4049\/jimmunol.1500258","article-title":"Human mucosa-associated Invariant T cells accumulate in colon Adenocarcinomas but produce reduced amounts of IFN-gamma","volume":"195","author":"Sundstrom","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.111892_b0155","doi-asserted-by":"crossref","first-page":"20358","DOI":"10.1038\/srep20358","article-title":"Circulating and tumor-infiltrating mucosal associated invariant T (MAIT) cells in colorectal cancer patients","volume":"6","author":"Ling","year":"2016","journal-title":"Sci. Rep."},{"issue":"46","key":"10.1016\/j.intimp.2024.111892_b0160","doi-asserted-by":"crossref","first-page":"76274","DOI":"10.18632\/oncotarget.11187","article-title":"Clinical relevance of circulating mucosal-associated invariant T cell levels and their anti-cancer activity in patients with mucosal-associated cancer","volume":"7","author":"Won","year":"2016","journal-title":"Oncotarget"},{"issue":"7423","key":"10.1016\/j.intimp.2024.111892_b0165","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nature11465","article-title":"Adenoma-linked barrier defects and microbial products drive IL-23\/IL-17-mediated tumor growth","volume":"491","author":"Grivennikov","year":"2012","journal-title":"Nature"},{"issue":"7556","key":"10.1016\/j.intimp.2024.111892_b0170","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature14282","article-title":"IL-17-producing gammadelta T cells and neutrophils conspire to promote breast cancer metastasis","volume":"522","author":"Coffelt","year":"2015","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.intimp.2024.111892_b0175","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.immuni.2014.03.013","article-title":"gammadeltaT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer","volume":"40","author":"Wu","year":"2014","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.intimp.2024.111892_b0180","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.4049\/jimmunol.1302701","article-title":"Mucosal-associated invariant T cell deficiency in systemic lupus erythematosus","volume":"193","author":"Cho","year":"2014","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2024.111892_b0185","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1084\/jem.190.9.1241","article-title":"Human G protein-coupled receptor GPR-9-6\/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis","volume":"190","author":"Zabel","year":"1999","journal-title":"J. Exp. Med."},{"issue":"12","key":"10.1016\/j.intimp.2024.111892_b0190","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/intimm\/dxn111","article-title":"Invariant Valpha7.2-Jalpha33 TCR is expressed in human kidney and brain tumors indicating infiltration by mucosal-associated invariant T (MAIT) cells","volume":"20","author":"Peterfalvi","year":"2008","journal-title":"Int. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2024.111892_b0195","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1182\/blood-2012-06-436436","article-title":"Early and nonreversible decrease of CD161++ \/MAIT cells in HIV infection","volume":"121","author":"Cosgrove","year":"2013","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.intimp.2024.111892_b0200","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1182\/blood-2012-07-445429","article-title":"Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection","volume":"121","author":"Leeansyah","year":"2013","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.intimp.2024.111892_b0205","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/intimm\/dxr047","article-title":"Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosis","volume":"23","author":"Miyazaki","year":"2011","journal-title":"Int. Immunol."},{"issue":"25","key":"10.1016\/j.intimp.2024.111892_b0210","doi-asserted-by":"crossref","first-page":"10299","DOI":"10.1073\/pnas.0703824104","article-title":"Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids","volume":"104","author":"Chang","year":"2007","journal-title":"PNAS"},{"issue":"11","key":"10.1016\/j.intimp.2024.111892_b0215","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1745-7254.2008.00889.x","article-title":"Tumor necrosis factor and cancer, buddies or foes?","volume":"29","author":"Wang","year":"2008","journal-title":"Acta Pharmacol. Sin."},{"issue":"4","key":"10.1016\/j.intimp.2024.111892_b0220","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.cytogfr.2014.07.018","article-title":"The IL-2 cytokine family in cancer immunotherapy","volume":"25","author":"Sim","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"issue":"23","key":"10.1016\/j.intimp.2024.111892_b0225","doi-asserted-by":"crossref","first-page":"19346","DOI":"10.18632\/oncotarget.5095","article-title":"Cytokine treatment in cancer immunotherapy","volume":"6","author":"Ardolino","year":"2015","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.intimp.2024.111892_b0230","first-page":"1271","article-title":"Tumor-infiltrating CD4+ Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer","volume":"25","author":"Iida","year":"2011","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.intimp.2024.111892_b0235","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.3390\/cancers3043856","article-title":"Cytokines in cancer immunotherapy","volume":"3","author":"Lee","year":"2011","journal-title":"Cancers (basel)"},{"issue":"8","key":"10.1016\/j.intimp.2024.111892_b0240","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nmeth.1483","article-title":"Going deeper than microscopy: the optical imaging frontier in biology","volume":"7","author":"Ntziachristos","year":"2010","journal-title":"Nat. Methods"},{"issue":"19","key":"10.1016\/j.intimp.2024.111892_b0245","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.1158\/1078-0432.CCR-12-2408","article-title":"The promise of patient-derived xenografts: the best laid plans of mice and men","volume":"18","author":"Kopetz","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.intimp.2024.111892_b0250","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1002\/art.34514","article-title":"Natural killer T cell deficiency in active adult-onset still's disease: correlation of deficiency of natural killer T cells with dysfunction of natural killer cells","volume":"64","author":"Lee","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2024.111892_b0255","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4172\/2157-7560.1000144","article-title":"Natural killer T cell based immunotherapy","volume":"3","author":"Subrahmanyam","year":"2012","journal-title":"J. Vaccines Vaccin"},{"issue":"26","key":"10.1016\/j.intimp.2024.111892_b0260","doi-asserted-by":"crossref","first-page":"6162","DOI":"10.1016\/j.biomaterials.2012.05.037","article-title":"Cell cycle arrest and apoptosis of OVCAR-3 and MCF-7 cells induced by co-immobilized TNF-alpha plus IFN-gamma on polystyrene and the role of p53 activation","volume":"33","author":"Guan","year":"2012","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.intimp.2024.111892_b0265","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1158\/0008-5472.CAN-10-2907","article-title":"Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer","volume":"71","author":"Tosolini","year":"2011","journal-title":"Cancer Res.."},{"issue":"7437","key":"10.1016\/j.intimp.2024.111892_b0270","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nature11824","article-title":"T-helper-1-cell cytokines drive cancer into senescence","volume":"494","author":"Braumuller","year":"2013","journal-title":"Nature"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924004107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924004107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T16:03:47Z","timestamp":1715616227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924004107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":54,"alternative-id":["S1567576924004107"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111892","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The quantity, function and anti-tumor effect of Mucosal associated invariant T cells in patients with bladder cancer","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111892","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111892"}}